Healthcare · Pharmaceuticals & Biotechnology
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.
Source: Wikipedia
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 20,103† | 20,030† | 17,645† | 16,247† | 15,521† |
| Net profit | 3,515 | 5,158 | 4,077 | 2,513 | — |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Achin Gupta | Executive Director | June 30, 2026 |
| Balram Bhargava | Independent Director | June 30, 2026 |
| Mandar Purushottam Vaidya | Independent Director | June 30, 2026 |
| Maya Hari | Independent Director | June 30, 2026 |
| Prathivadibhayankara Rajagopalan Ramesh | Independent Director | June 30, 2026 |
| Sharmila Paranjpe | Independent Director | June 30, 2026 |
| Abhijit Jagdish Joshi | Non-Executive Director | June 30, 2026 |
| Adil Zainulbhai | Non-Executive Director | June 30, 2026 |
| Kamil Hamied | Non-Executive Director | June 30, 2026 |
| Y K Hamied | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
